جستجوی استاد راهنمای دانشگاهی

Hyun (Michel) Koo is a Professor at the University of Pennsylvania School of Dental Medicine , with affiliations in the Department of Orthodontics , Division of Community Oral Health , and Division of Pediatric Dentistry . As Co-Founder and Co-Director of the Center for Innovation & Precision Dentistry (CiPD) , he leads interdisciplinary efforts merging bioengineering, nanotechnology, and oral health research. Education : DDS and PhD Research Focus : Biofilms, bacterial-fungal interactions, and nanotechnology for oral disease prevention Leadership : Co-Director of CiPD; key roles in training programs like NIDCR-sponsored R90 and T90/R90 Dr. Koo’s research explores biofilm mechanisms in oral infectious diseases, particularly childhood caries, through engineering methods and microrobotics . His team developed micron-scale robots for automated biofilm eradication and FDA-approved nanoparticles for caries prevention. Collaborations with Penn Engineering, including Dr. Daeyeon Lee and Dr. Kacy Cullen, emphasize translational approaches. The 15 most recent publications highlight his work in nanorobotics , interkingdom biofilms , and precision diagnostics . Articles span 2025–2024 and address topics like adaptive micromotors , biofilm matrix degradation , and single-cell microbial interactions . These emphasize his focus on targeted therapies and biofilm microenvironment engineering . Key Awards : Elected Fellow, American Association for the Advancement of Science (AAAS) IADR Distinguished Scientist Award for innovative dental research Dr. Koo trains next-generation researchers through the CiPD NIDCR T90/R90 Postdoctoral Training Program , mentoring fellows like Smruti Nair (ACE2 Chewing Gum development) and Zhi Ren (K99 awardee). His work intersects with Penn Health-Tech, CT3N , and Penn Institute for Biomedical Informatics , fostering transdisciplinary innovation.

• Biofilms
• Oral Infectious Diseases
• Nanotechnology
• +۳ مورد دیگر

Christopher M. Overall is a Full Professor at the University of British Columbia in the Faculty of Dentistry, Department of Oral Biological and Medical Sciences . He is also a Principal Scientist at the Centre for Blood Research and holds associate memberships in UBC's Biochemistry & Molecular Biology , Obstetrics and Gynecology , and Bioinformatics Graduate Program departments. As a Canada Research Chair Laureate , he pioneered the field of degradomics to study proteases in vivo. B.D.S., University of Adelaide Ph.D., University of Toronto Postdoctoral Fellowship, UBC (with Nobel Laureate Michael Smith) Dr. Overall’s research focuses on protease proteomics and systems biology , particularly degradomics to analyze protease substrates in diseases like COVID-19 and immunodeficiency . His work on matrix metalloproteinases has revealed new therapeutic strategies for inflammatory diseases and cancer . His 15 most recent articles (2015–2008) demonstrate expertise in TAILS proteomics , protein terminomics , and protease network analysis with applications in arthritis , antiviral immunity , and precision medicine . Scientific Awards 2022 Helmut Holzer Award 2018 Royal Society of Canada Fellow 2014 Tony Pawson Canadian Proteomics Award 2013 IADR Distinguished Scientist Award Dr. Overall has mentored 61 trainees , including 9 full professors with department chairs, and received the UBC John McNeill Mentorship Award (2023). He leads the HUPO Chromosome-centric Human Proteome Project and consults for Genentech and Novartis .

• Protease Proteomics
• Systems Biology
• Degradomics
• +۶ مورد دیگر

Dr. William V. Giannobile serves as the Dean and A. Lee Loomis, Jr. Professor of Oral Medicine, Infection, and Immunity at Harvard School of Dental Medicine (HSDM). He leads the institution as its chief academic and administrative officer while maintaining an active research program and clinical practice in periodontics and implant dentistry at the Harvard Dental Center in Cambridge, MA. Dr. Giannobile received his DDS and MS in oral biology from the University of Missouri, followed by a certificate in periodontology and Doctor of Medical Sciences (DMSc) in oral biology from Harvard School of Dental Medicine. He completed postdoctoral training in molecular biology at the Dana-Farber Cancer Institute and Harvard Medical School. With over 30 years of continuously NIH-funded research, Dr. Giannobile's work focuses on oral and periodontal regenerative medicine, tissue engineering, and precision medicine. He serves as principal investigator of the NIDCR U-Award Harvard Clinical Practice-based Research Program for Dental Students (H-CREDENT), which evaluates the genomics of oral pain in a multi-institutional academic setting. His research has produced over 300 manuscripts, textbook chapters, and patents focused on periodontology, regenerative medicine, and oral health research. He has edited or co-edited over 10 books in clinical and translational research, periodontology, and regenerative medicine. His publications demonstrate consistent focus on periodontal regeneration, biomaterials, tissue engineering, and the molecular mechanisms underlying oral diseases. ADA Gold Medal Award for Excellence in Dental Research (2024) International Association for Dental Research Distinguished Scientist Research in Periodontal Disease Award (2022) Norton M. Ross Clinical Research Award from the American Dental Association (2018) William J. Gies Award (2014) Jan Lindhe International Periodontology Research Award (2011) As an educator and mentor, Dr. Giannobile completed a 10-year term as editor-in-chief for the Journal of Dental Research, the official journal of the International Association for Dental Research. He has served as a consultant to the U.S. Food and Drug Administration for Dental Devices and as an associate editor for the NIDCR Report on Oral Health of the U.S. in 2021. His laboratory continues to advance research in periodontal regeneration and precision medicine approaches to oral health, with ongoing NIH funding supporting innovative translational research.

• Periodontology
• Regenerative Medicine
• Tissue Engineering
• +۳ مورد دیگر

Laurent Tapie is a Senior Lecturer at Paris Descartes University with a focus on Biomedical Engineering, Mechanical Engineering, and CAD/CAM . As Deputy Director of the URB2i research unit and manager of the PlatiNum platform , he coordinates the 3d4care.org consortium . His academic background includes a Doctorate in Mechanical Engineering from École Normale Supérieure de Cachan and authorization to direct research (HDR) from Université Paris 13. Research Interests: Mechanical Engineering, Biomedical Engineering, Medical Devices, CAD/CAM, Shaping of Biomaterials Theses Supervised: 3D evaluation of dento-prosthetic joints, impact of CAD/CAM on dental prosthesis integrity, and metrological evaluations of prostheses. Publications: His work spans dental CAD/CAM systems, surface integrity of prostheses, additive manufacturing, and 3D printing applications during the COVID-19 pandemic . Recent articles focus on data dispersion in CAD/CAM chains, tool-material influence on roughness, and numerical workflow standardization . Scientific Award: Prix du comité scientifique de la session recherche (2019). Projects: Currently leads initiatives like ProGéoMéca (Labex LaSIPS), Bio-Dents (CNRS Biomimicry), and additive process development for multi-material dental aligners .

• Mechanical Engineering
• Biomedical Engineering
• Medical Devices
• +۵ مورد دیگر

Professor Heiko Spallek is Head of School and Dean at the University of Sydney’s Sydney Dental School, leading the school’s integration with the Faculty of Medicine and Health. He also serves as Academic Lead for Digital Health and Health Service Informatics at the faculty level. His research focuses on advancing dental informatics, teledentistry, and evidence-based practice, while advocating for improved oral health policy and public health initiatives. He holds roles including director at Community Connections Australia and membership in the Charles Perkins Centre. Education: DMD, Dr. med. dent., MSBA(CIS), FACD, FAIDH Leadership: Oversees Sydney Dental School’s academic and clinical programs, emphasizing interprofessional education and digital health innovation. Research interests include leveraging big data and machine learning in dentistry, improving access to oral healthcare through teledentistry, and addressing systemic issues in dental education and policy. He has led projects on laser dentistry applications, dental caries prevention, and healthcare workforce regulation. Notable contributions include the OpenWide conference series, the BigMouth dental data repository, and advocacy for equitable dental funding in Australia. Grants include initiatives on oral hygiene in aged care and analysis of healthcare advertising perceptions. Media engagements highlight his role in public discourse on dental access and policy, including commentary on Australia’s dental crisis and aged care reforms. He actively promotes interdisciplinary collaboration through platforms like the Dental Informatics Online Community. Labs/Teams: Directs the Sydney Dental School’s research programs in informatics and public health, collaborating with national and international networks such as the National Dental PBRN.

• Dental Informatics
• Teledentistry
• Oral Health Policy
• +۴ مورد دیگر

Martin Gosau is a Professor at the Clinic and Polyclinic for Oral and Maxillofacial Surgery within the Medical Faculty of the University Medical Center Hamburg-Eppendorf (UKE). His research focuses on Oral Surgery , Maxillofacial Surgery , and Regenerative Medicine , with a strong emphasis on Dental Implants , Head and Neck Cancer , and Oral Pathology . University: University Medical Center Hamburg-Eppendorf School: Medical Faculty Department: Oral and Maxillofacial Surgery Academic Rank: Professor His recent work explores: Oral Health in Genetic Disorders (e.g., hypophosphatasia) Advanced Surgical Techniques (e.g., nanosecond lasers, fluorescence angiography) Biomaterials and Tissue Engineering (e.g., silk fibroin membranes, extracellular vesicles) Cancer Prognostics (e.g., DCBLD1 overexpression in HNSCC) Key trends in his 15 most recent articles include applications of machine learning in oral diagnostics, stem cell research for bone regeneration, and biomaterials in reconstructive surgery. He frequently collaborates with Ralf Smeets and Thomas Vollkommer , with publications spanning Frontiers in Immunology , Oral Surgery , and Scientific Reports .

• Oral Surgery
• Maxillofacial Surgery
• Head and Neck Cancer
• +۱۲ مورد دیگر

Professor Moritz Rossner serves as Head of the Department of Molecular and Behavioral Neurobiology at the Department of Psychiatry and Psychotherapy, Faculty of Medicine, Ludwig-Maximilians-Universität München (LMU). His research integrates molecular and behavioral approaches to understand the neurobiological underpinnings of psychiatric disorders, particularly schizophrenia and bipolar disorder. Rossner's research interests focus on molecular neurobiology and behavioral analysis using mouse models. His laboratory employs advanced techniques including mouse genetics , behavioral phenotyping , biosensors , next-generation sequencing , and transcriptomics to investigate psychiatric risk genes and pathways. His work bridges cellular and molecular mechanisms with behavioral outcomes, particularly in schizophrenia and bipolar disorder research. Analysis of Rossner's 15 most recent publications (2025) reveals a strong focus on precision psychiatry , neuroimaging biomarkers , and genetic mechanisms underlying psychiatric disorders. His research increasingly incorporates multimodal approaches combining neuroimaging, genomics, and clinical phenotyping to develop biologically informed diagnostic and treatment frameworks. Key themes include blood-brain barrier dysfunction in schizophrenia, inflammatory contributions to symptom severity, and pathway-specific polygenic scores for treatment prediction. Rossner leads the Molecular & Behavioural Neurobiology working group at LMU's Department of Psychiatry and Psychotherapy, which includes specialized units like the Mouse Behavioral Unit. His research program appears well-funded through multiple collaborative projects focused on understanding the molecular basis of psychiatric disorders and developing novel therapeutic approaches.

• Molecular Neurobiology
• Behavioral Neurobiology
• Mouse Genetics
• +۷ مورد دیگر

Betsy Foxman serves as the Hunein F. and Hilda Maassab Professor of Epidemiology at the University of Michigan School of Public Health. She directs three major initiatives: the Center for Molecular and Clinical Epidemiology of Infectious Diseases, the Integrated Training in Microbial Systems program, and the Certificate in Healthcare Infection Prevention & Control. Her academic leadership spans decades with continuous research contributions. Dr. Foxman earned her PhD and MSPH from UCLA (1983, 1980) and BS from UC Berkeley (1977). Her research centers on infectious disease transmission, microbiome ecology, antibiotic resistance, and wastewater surveillance . Key projects include analyzing the oral microbiome in dental caries using genomic methods, studying nose/throat microbiome associations with respiratory infections in nursing facilities, and developing wastewater monitoring for antibiotic-resistant pathogens. Her work integrates next-generation sequencing with epidemiological analysis to identify novel interventions. Publication trends reveal consistent focus on microbiome-pathogen interactions across multiple body sites (oral, vaginal, gut, respiratory). Recent articles demonstrate methodological innovation in wastewater epidemiology (2024 Norovirus GII monitoring) and clinical applications like predicting vancomycin-resistant enterococci contamination (2023 Lancet study). Her research bridges molecular microbiology with population health, emphasizing translational potential for diagnostics and public health interventions. Fellow of the Infectious Disease Society of America Fellow of the American College of Epidemiology Fellow of the American Academy of Microbiology Dr. Foxman's advising portfolio includes numerous NIH-funded projects on microbiome dynamics and infection control. Her leadership in the Center for Molecular and Clinical Epidemiology drives collaborative research across departments. Current initiatives focus on wastewater surveillance standardization and microbiome-based diagnostics for infection prevention. She maintains active laboratories for genomic analysis of microbial communities and clinical sample processing.

• Infectious Disease Epidemiology
• Human Microbiome Research
• Antibiotic Resistance
• +۵ مورد دیگر

Rachel Hess, MD, MS is Professor of Population Health Sciences and Internal Medicine and Associate Vice President for Research-Health Sciences at the University of Utah Schools of the Health Sciences. She co-directs the Utah Clinical and Translational Science Institute and was founding Chief of the Division of Health System Innovation and Research (2014-2022). A board-certified General Internist and internationally recognized health-services researcher, she focuses on translating evidence into practice through health-information technology and patient-centered outcomes. Education & Training MD – University of New Mexico School of Medicine MS Clinical Research – University of Pittsburgh Fellowship – General Internal Medicine & Women’s Health, University of Pittsburgh / VA Pittsburgh Medical Center Chief Residency – Internal Medicine, Western Pennsylvania Hospital Residency – Internal Medicine, Temple University Hospital BA Mathematics – Washington University in St. Louis Research Focus Dr Hess’s program is dedicated to improving patient-centered outcomes by leveraging implementation science, health-information technology, and patient-reported measures. Her work spans: Design and nationwide deployment of EHR-integrated clinical decision support for cancer genetics, lung-cancer screening, heart-failure management, and antibiotic stewardship. Large multi-site pragmatic trials (ADAPTABLE, RECOVER, BRIDGE, MAINTAIN) examining effectiveness, equity, and scalability of digital-health interventions. Women’s health across the lifespan, including studies on menopause, sexual function, and post-COVID sequelae. Advanced analytics linking patient-reported outcomes (PROs) with healthcare utilization and cost. Scientific Awards & Recognition Board Certification, American Board of Internal Medicine (Internal Medicine) Leadership of NIH RECOVER Consortium adult cohort—one of the largest studies of Long COVID worldwide Principal investigator on >$50 million in federal and foundation funding (PCORI, NHLBI, NCI, AHRQ, CDC) Leadership & Service As Associate Vice President for Research she sets strategic priorities for the Schools of Medicine, Nursing, Pharmacy, Dentistry, and Health. She co-chairs the Utah Clinical and Translational Science Institute, oversees campus-wide clinical-trials infrastructure, and mentors interdisciplinary teams spanning informatics, behavioral science, epidemiology, and clinical medicine. Laboratories & Teams Dr Hess leads the Health System Innovation and Research (HSIR) group—an interdisciplinary unit of data scientists, implementation researchers, clinicians, and patient partners—dedicated to rapid-cycle testing and national scale-up of digital-health solutions.

• Health services research
• Implementation science
• Patient-reported outcomes
• +۶ مورد دیگر

Dr. Kenneth Y. Usuki serves as an Associate Professor in the Department of Radiation Oncology at the University of Rochester School of Medicine and Dentistry. He is a board-certified Radiation Oncologist actively practicing at the Wilmot Cancer Center and Strong Memorial Hospital, specializing in neuro-oncology, radiosurgery, and gastrointestinal cancers. His clinical leadership includes roles as Co-Director of the Spinal Radiosurgery Program, Associate Radiation Oncology Residency Director, and Medical Student Clerkship Director. Dr. Usuki earned his MD from Jefferson Medical College (2004), completed a Transitional Year Internship at Penn Presbyterian Medical Center (2004-2005), and underwent Radiation Oncology Residency at the University of Rochester Medical Center (2005-2009), where he served as chief resident. His research focuses on optimizing radiation techniques for brain/spine tumors, skin cancers, and gastrointestinal malignancies. His research demonstrates consistent innovation in stereotactic radiosurgery, with recent publications (2023-2024) emphasizing brain metastasis management, cognitive preservation during whole-brain radiation, and advanced dosimetry techniques. Key trends include hippocampal avoidance protocols, multi-target radiosurgery planning, and systemic disease interactions with CNS control – reflecting his dual focus on technical precision and patient-centered outcomes. His work frequently appears in high-impact journals like International Journal of Radiation Oncology, Biology, Physics and Advances in Radiation Oncology . Dr. Usuki actively mentors residents and medical students through formal educational leadership roles. His departmental responsibilities include residency program oversight, medical student clerkship direction, and serving as Wellness Representative for the Department of Radiation Oncology. He contributes to major collaborative trials including NRG Oncology CC001. As Co-Director of the University of Rochester Spinal Radiosurgery Program, he leads a specialized team applying cutting-edge techniques like Brain Lab Cranial Elements SRS, VMAT, and Image-Guided Radiation Therapy to complex spinal pathologies. The program emphasizes multidisciplinary collaboration between radiation oncology, neurosurgery, and medical oncology teams.

• Neuro-oncology
• Radiation Therapy
• Stereotactic Radiosurgery
• +۲ مورد دیگر

Dr. Emma Magavern is a Clinical Lecturer and Clinical Pharmacology specialist at Queen Mary University of London's Faculty of Medicine and Dentistry, affiliated with the William Harvey Research Institute. She holds a unique academic-clinical position, splitting her time 50% between clinical work and research. Her PhD in pharmacogenomics explored genetic influences on drug response, and she now focuses on leveraging genomic medicine to address health disparities. Key roles include co-secretary of the Royal College of Physicians/British Pharmacological Society pharmacogenomics working group and co-lead for the NHS England Pharmacogenomics Network of Excellence. She also chairs the British Pharmacological Society SpR Committee and contributes to the Health Education England GeNotes initiative. Education: BA in English, MD, MSc in Bioethics, MSc in Genomics Research: Investigates how genetic variants affect medication efficacy/safety, particularly in underrepresented groups like British South Asians. Recent work highlights CYP2C19 variants reducing clopidogrel effectiveness in this population. Public Engagement: Develops patient/prescriber resources, surveys public attitudes on pharmacogenomics, and advocates for inclusive genomic medicine practices. Her research emphasizes translating genetic insights into clinical practice to improve personalized medicine while ensuring equitable access. Collaborators include Prof. Mark Caulfield and Prof. Damian Smedley, with funding from Barts Charity and the NIHR Biomedical Research Centre.

• Pharmacogenomics
• Genomic Medicine
• Clinical Pharmacology
• +۳ مورد دیگر

Professor Jinman Kim is a Professor in the School of Computer Science at the University of Sydney and Director of the Biomedical Data Analysis and Visualisation (BDAV) Lab. He also serves as Research Director of the Telehealth and Technology Centre at Nepean Hospital. His research focuses on machine learning applications in biomedical image analysis, visualization, and multi-modal data processing. Kim holds a PhD in Computer Science from the University of Sydney (2006) and has held roles including Senior Lecturer (2013), Associate Professor (2016), and Professor (2022). He is an Area Editor for Computer Methods and Programs in Biomedicine and actively contributes to AI-driven healthcare initiatives. His academic journey includes a Marie Curie Fellowship at the University of Geneva (2010) and leadership roles in projects like the ARC Training Centre in Innovative Biomedical Engineering. He co-leads the Digital Health Imaging initiative under the Faculty of Engineering’s Digital Science Initiative. Kim has developed teaching programs such as the Master of Digital Health and Data Science, co-taught with the Faculty of Medicine and Health. Research interests span AI in medical imaging, telehealth systems, and interdisciplinary biomedical engineering. His work includes advancements in PET/CT fusion, tumor segmentation, and medical visual analytics. Kim’s lab explores applications like AI in dental education, cutaneous lymphoma detection, and fair AI models for healthcare. Notable collaborations include the Telehealth Remote Monitoring System for chronic patients and contributions to datasets like the HRDC Challenge for hypertension classification. His labs prioritize translating AI innovations into clinical tools for improved healthcare accessibility and precision.

• Machine Learning
• Biomedical Image Analysis
• Medical Imaging
• +۳ مورد دیگر

Ram Samudrala is a Professor and Chief of the Division of Bioinformatics at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences . His research focuses on multiscale computational biology , integrating protein structure prediction , drug discovery , and translational science to address medical challenges. He leads the development of the CANDO platform for therapeutic drug discovery and co-directs the Informatics Core at the Clinical and Translational Sciences Institute. PhD in Computational Biology (University of Maryland, 1997) BA in Computing Science and Genetics (Ohio Wesleyan University, 1993) Postdoctoral Fellowship in Protein Folding (Stanford University, 1997-2001) His work spans structural biology , genomics , and computational drug design , with applications in dentistry , infectious diseases , and cancer . He has received prestigious awards including the NIH Director's Pioneer Award (2010) and multiple Wiki Science Prizes . Samudrala's group collaborates globally, emphasizing in silico methods followed by in vitro and in vivo validation. Key grants include $1.22M NIH NCATS ASPIRE Reduction-to-Practice Award and $4.5M NIH/NLM BRIGHT Training Grant . 2023 Finalist, Clinical and Translational Sciences Institute Clinical Research Achievement Awards 2016 MacArthur Foundation 100&Change Top 50 2008 Alberta Heritage Foundation Visiting Scientist Award 2005 NSF CAREER Award He directs the BRIGHT Short-Term Training Program and serves on multiple editorial boards and review panels. Samudrala's group maintains a Protinfo web server for structural predictions and the Bioverse framework for systems-level analyses.

• Bioinformatics
• Computational Biology
• Drug Discovery
• +۱۰ مورد دیگر

Jennifer W. Caceres, M.D., F.A.C.P., is Vice Dean for Medical Education and Professor of Medicine at Florida Atlantic University's Charles E. Schmidt College of Medicine. She has held leadership roles in medical education and student affairs since joining FAU in 2014, previously serving at the University of Miami Miller School of Medicine's Regional Campus (2008-2014). Her work focuses on career advising, wellness programs, and quality improvement initiatives. 1999: B.S. in Biology with Highest Honors, Rutgers University 2002: M.D., University of Medicine and Dentistry of New Jersey (articulated BA/MD program with Rutgers) 2002-2005: Internal Medicine Internship and Residency, New York Medical College at Saint Vincent's Catholic Medical Center Dr. Caceres specializes in Quality Improvement and Patient Safety , with research on reducing hospital readmissions, developing educational curricula for internal medicine residencies, and addressing medical student wellness. She also explores social media impacts and infectious disease policy . Her recent publications highlight trends in opioid overdose mortality , medical student wellbeing , cyberbullying , vaccine hesitancy , and innovative discharge protocols . These works span public health, clinical research, and educational interventions. Scientific Awards 2023 Faculty Talon Leadership Award, FAU 2023 Michael L. Friedland Educational Leadership Award, FAU Medicine 2021 Palm Beach County Medical Society Heroes in Medicine Finalist 2019 Leonard Tow Humanism in Medicine Award 2016 Gold Humanism Honor Society Inductee 2014 University of Miami Teaching/Leadership Award 2011 Project Access Provider of the Year Dr. Caceres mentors medical students and residents in scholarly work, including peer-reviewed publications and national presentations. She also leads community initiatives like the Run for the Health of It, a 5K charitable event in Palm Beach County.

• Quality Improvement
• Patient Safety
• Medical Student Wellness
• +۷ مورد دیگر

Professor Nikolas P Lemos is a chartered forensic scientist and director of the Cameron Forensic Medical Sciences unit at Queen Mary University of London's William Harvey Research Institute. He holds academic affiliations with institutions in San Francisco, St Louis, and Athens, focusing on forensic toxicology, postmortem analysis, and drug-facilitated crimes. His career includes roles as Chief Forensic Toxicologist in San Francisco and Head of Forensic Toxicology at St George's University of London. His research emphasizes cannabinoids in forensic contexts, drug analysis in keratinous matrices (nails/fingernails), and forensic laboratory accreditation standards. He has co-authored over 85 peer-reviewed publications, including landmark studies on cannabinoid detection in postmortem toxicology and fingernail analysis. Professor Lemos is actively engaged in professional organizations, serving as Chair of the Toxicology Section of the American Academy of Forensic Sciences. He has provided expert testimony in over 325 criminal and civil cases globally, addressing forensic toxicology matters related to drug-facilitated crimes, driving under influence cases, and postmortem redistribution phenomena. Key achievements include designing forensic laboratory facilities in San Francisco, coordinating NAME/ABFT accreditations, and receiving a Congressional Proclamation of Achievement (2005) for contributions to community safety. His work bridges forensic science with legal systems, particularly in drug policy and toxicological evidence interpretation.

• Forensic Toxicology
• Cannabis Toxicology
• Post-mortem Toxicology
• +۵ مورد دیگر